44 results on '"Mahler, Donald A."'
Search Results
2. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD
3. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review
4. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers
5. Inflammation in COPD: Implications for Management
6. Mechanism of Greater Oxygen Desaturation During Walking Compared With Cycling in Patients With COPD
7. Advantages of Endurance Treadmill Walking Compared With Cycling To Assess Bronchodilator Therapy
8. American College of Chest Physicians Consensus Statement on the Management of Dyspnea in Patients With Advanced Lung or Heart Disease
9. Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease
10. Perceptual and Physiologic Responses During Treadmill and Cycle Exercise in Patients With COPD
11. REMOTELY RECORDED PEAK INHALATION FLOW PATTERNS AMONG PATIENTS WITH COPD USING PROAIR DIGIHALER FOR RESCUE MEDICATION
12. Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD
13. Meaningful effect size and patterns of response of the transition dyspnea index
14. Evaluation of dyspnea in the elderly
15. Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD
16. How Should Health-Related Quality of Life Be Assessed in Patients With COPD?
17. Efficacy of Salmeterol Xinafoate in the Treatment of COPD
18. Enhanced Drug and Device Development by Targeting “Relief of Dyspnea”
19. PREDICTORS OF SUBOPTIMAL PEAK INSPIRATORY FLOW RATE IN PATIENTS WITH COPD: ANALYSES FROM THE REVEFENACIN PHASE-3 PROGRAM
20. Chapter 19 - Dyspnea
21. Patients With Severe COPD Show Significant Improvements in Dyspnea and Lung Function With Once-Daily QVA149: The Blaze Study
22. Once-Daily QVA149 Demonstrates Superior Improvements in Patient-Reported Dyspnea Compared to Tiotropium in Patients With Moderate-to-Severe COPD: The BLAZE Study
23. Development and Validation of an Innovative Self-Administered Computerized Version of Baseline/Transition Dyspnea Index for Evaluating Breathlessness in Patients With COPD: The BLAZE Study
24. Antagonism of Substance P and Perception of Dyspnea and Pain in Patients With COPD
25. Predictors of Peak Inspiratory Flow Rate (PIFR) in Advanced COPD
26. Intralobar Pulmonary Sequestration in an Adult
27. Contributors
28. Responsiveness of Self-Reported Dyspnea Instruments in Patients With Chronic Obstructive Pulmonary Disease
29. EFFECT OF ARFORMOTEROL TWICE DAILY, TIOTROPIUM ONCE DAILY, AND THEIR COMBINATION IN SUBJECTS WITH COPD
30. COMPREHENSIVE MEASUREMENT OF BREATHLESSNESS USING THE SELF-ADMINISTERED COMPUTERIZED VERSIONS OF THE BASELINE AND TRANSITION DYSPNEA INDEXES
31. CONTRIBUTORS
32. Are You Fluent in the Language of Dyspnea?
33. Dyspnea Ratings for Prescription of Cross-Modal Exercise in Patients With COPD
34. Evaluation of the Short-Form 36-Item Questionnaire to Measure Health-Related Quality of Life in Patients With COPD
35. Acute Effects of Passive Smoking on Lung Function and Airway Reactivity in Asthmatic Subjects
36. Impact of Dyspnea and Physiologic Function on General Health Status in Patients with Chronic Obstructive Pulmonary Disease
37. Measurement of Respiratory Sensation in Interstitial Lung Disease: Evaluation of Clinical Dyspnea Ratings and Magnitude Scaling
38. Salmeterol Reduces Dyspnea and Improves Lung Function in Patients With COPD
39. Right Ventricular Function at Rest and during Exercise in Chronic Obstructive Pulmonary Disease
40. The Role of Theophylline in the Treatment of Dyspnea in COPD
41. Positional Dyspnea and Oxygen Desaturation Related to Carcinoma of the Lung: Up with the Good Lung
42. Looped Bronchoscope
43. Theoretical Basis for Usefulness of Dyspnea Ratings for Prescription of Exercise in COPD Patients
44. MANAGING ASTHMA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.